News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
670,853 Results
Type
Article (57538)
Company Profile (78)
Press Release (613223)
Multimedia
Podcasts (113)
Webinars (21)
Section
Business (175330)
Career Advice (2733)
Deals (32928)
Drug Delivery (132)
Drug Development (76591)
Employer Resources (159)
FDA (15264)
Job Trends (14120)
News (307820)
Policy (29925)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (2)
Academia (2729)
Academic (2)
Accelerated approval (41)
Adcomms (30)
Allergies (162)
Alliances (44060)
ALS (188)
Alzheimer's disease (1659)
Antibody-drug conjugate (ADC) (351)
Approvals (15596)
Artificial intelligence (612)
Autoimmune disease (229)
Automation (46)
Bankruptcy (300)
Best Places to Work (10934)
BIOSECURE Act (20)
Biosimilars (189)
Biotechnology (54)
Bladder cancer (176)
Brain cancer (68)
Breast cancer (674)
Cancer (5242)
Cardiovascular disease (436)
Career advice (2338)
Career pathing (44)
CAR-T (314)
CDC (56)
Celiac Disease (2)
Cell therapy (831)
Cervical cancer (41)
Clinical research (66290)
Collaboration (1880)
Company closure (6)
Compensation (771)
Complete response letters (74)
COVID-19 (2656)
CRISPR (103)
C-suite (1038)
Cystic fibrosis (150)
Data (6903)
Decentralized trials (2)
Denatured (43)
Depression (155)
Dermatology (52)
Diabetes (519)
Diagnostics (6684)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (41)
Drug discovery (292)
Drug pricing (218)
Drug shortages (26)
Duchenne muscular dystrophy (241)
Earnings (65063)
Editorial (64)
Employer branding (19)
Employer resources (141)
Events (100929)
Executive appointments (1090)
FDA (18687)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (12)
Frontotemporal dementia (29)
Funding (1601)
Gene editing (218)
Generative AI (54)
Gene therapy (623)
GLP-1 (961)
Government (4867)
Grass and pollen (8)
Guidances (392)
Healthcare (18492)
HIV (71)
Huntington's disease (45)
IgA nephropathy (84)
Immunology and inflammation (243)
Immuno-oncology (81)
Indications (148)
Infectious disease (2957)
Inflammatory bowel disease (200)
Inflation Reduction Act (15)
Influenza (124)
Intellectual property (269)
Interviews (527)
IPO (15098)
IRA (59)
Job creations (3497)
Job search strategy (1931)
JPM (64)
Kidney cancer (19)
Labor market (83)
Layoffs (603)
Leadership (39)
Legal (6734)
Liver cancer (94)
Longevity (25)
Lung cancer (698)
Lymphoma (395)
Machine learning (49)
Management (54)
Manufacturing (874)
MASH (177)
Medical device (13086)
Medtech (13162)
Mergers & acquisitions (19014)
Metabolic disorders (1357)
mRNA (179)
Multiple sclerosis (164)
NASH (16)
Neurodegenerative disease (360)
Neuropsychiatric disorders (96)
Neuroscience (3004)
Neurotech (1)
NextGen: Class of 2026 (6448)
Non-profit (4481)
Now hiring (27)
Obesity (626)
Opinion (318)
Ovarian cancer (184)
Pain (227)
Pancreatic cancer (251)
Parkinson's disease (321)
Partnered (34)
Patents (551)
Patient recruitment (609)
Peanut (61)
People (60842)
Pharmaceutical (18)
Pharmacy benefit managers (29)
Phase 1 (20981)
Phase 2 (29293)
Phase 3 (21326)
Pipeline (6941)
Policy (320)
Postmarket research (2354)
Preclinical (8780)
Press Release (64)
Prostate cancer (275)
Psychedelics (44)
Radiopharmaceuticals (303)
Rare diseases (966)
Real estate (6095)
Recruiting (68)
Regulatory (23178)
Reports (42)
Research institute (2563)
Resumes & cover letters (408)
Rett syndrome (33)
RNA editing (15)
RSV (76)
Schizophrenia (160)
Series A (273)
Series B (194)
Service/supplier (8)
Sickle cell disease (103)
Special edition (19)
Spinal muscular atrophy (162)
Sponsored (44)
Startups (3424)
State (1)
Stomach cancer (13)
Supply chain (105)
Tariffs (74)
The Weekly (67)
Vaccines (1032)
Venture capital (89)
Weight loss (385)
Women's health (100)
Worklife (23)
Date
Last 7 days (612)
Last 30 days (2342)
Last 365 days (28462)
2026 (7555)
2025 (28803)
2024 (32469)
2023 (36614)
2022 (46983)
2021 (51860)
2020 (50982)
2019 (45001)
2018 (34361)
2017 (30742)
2016 (30078)
2015 (35417)
2014 (28405)
2013 (24734)
2012 (26023)
2011 (26267)
2010 (24656)
Location
Africa (883)
Alabama (93)
Alaska (7)
Arizona (259)
Arkansas (14)
Asia (40324)
Australia (7045)
California (11211)
Canada (3268)
China (1233)
Colorado (491)
Connecticut (477)
Delaware (356)
Europe (91403)
Florida (1709)
Georgia (382)
Hawaii (3)
Idaho (59)
Illinois (956)
India (79)
Indiana (507)
Iowa (20)
Japan (462)
Kansas (124)
Kentucky (46)
Louisiana (39)
Maine (75)
Maryland (1367)
Massachusetts (7925)
Michigan (352)
Minnesota (613)
Mississippi (7)
Missouri (148)
Montana (36)
Nebraska (25)
Nevada (126)
New Hampshire (87)
New Jersey (3142)
New Mexico (30)
New York (3080)
North Carolina (1473)
North Dakota (9)
Northern California (5466)
Ohio (348)
Oklahoma (25)
Oregon (41)
Pennsylvania (2223)
Puerto Rico (25)
Rhode Island (42)
South America (1189)
South Carolina (62)
South Dakota (1)
Southern California (4489)
Tennessee (192)
Texas (1833)
United States (40329)
Utah (350)
Vermont (1)
Virginia (280)
Washington D.C. (74)
Washington State (914)
West Virginia (4)
Wisconsin (130)
Wyoming (2)
670,853 Results for "shanghai institute of materia medica simm".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Global Study From Feinstein Institutes to Unlock Secrets of Lupus Remission
March 18, 2026
·
5 min read
Press Releases
Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference
March 27, 2026
·
4 min read
Press Releases
RAPT Therapeutics and Shanghai Jeyou Pharmaceutical Announce Positive Topline Data from Phase 2 Trial of RPT904 (JYB1904) in Chronic Spontaneous Urticaria
October 21, 2025
·
9 min read
Press Releases
Auragens Officially Launches Dedicated Orthobiologics Division, A First in the Field by a Regenerative Medicine and Research Institute
March 10, 2026
·
3 min read
Press Releases
Parker Institute for Cancer Immunotherapy Announces Appointment of Bob Purcell as Chief Communications Officer
February 25, 2026
·
3 min read
Breakthrough Discoveries on Novel Features of Omicron Variant and An Anti-Omicron Antibody JMB2002
Joint research results from Biologics of Jemincare and Shanghai Institute of Materia Medica (SIMM) of Chinese Academy of Sciences (CAS) confirmed that JMB2002, an anti-SARS-CoV-2 neutralizing antibody (NAb) discovered by Biologics of Jemincare is still effective against Omicron variant of SARS-CoV-2.
January 3, 2022
·
3 min read
Business
Outstanding Traditional Chinese Medicine Vitiligo Treatment Institution Establishes Itself in Shanghai, Aiming to Provide Specialized Treatment Solutions to More International Patients
Recently has unveiled a remarkable announcement: the inauguration of the Huahai Institute of Vitiligo Research in Shanghai.
September 26, 2023
·
5 min read
Press Releases
Panoramic Health and West Coast Kidney Institute Launch Concord Cardio-Renal Research Institute to Advance Clinical Trials in Cardio-Renal-Metabolic Disease
April 2, 2026
·
3 min read
Deals
Donaldson Enters into Agreement to Acquire Minority Stake in Medica, S.p.A.
Donaldson Company, Inc., a leading worldwide provider of innovative filtration products and solutions, announced it has entered into a definitive agreement allowing the Company to purchase a 49% stake in Medica S.p.A.
April 29, 2024
·
5 min read
UroFiber SuperPulsed Thulium Fiber Laser System Officially Debuts at MEDICA 2023
UroFiber SuperPulsed Thulium Fiber Laser System, developed by Rhein Laser Technologies Ltd., a pioneer in medical laser technology, made its first appearance at the esteemed MEDICA 2023 in Germany.
November 30, 2023
·
2 min read
Previous
2 of 67,086
Next
